Cargando…
Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer
SIMPLE SUMMARY: Biliary tract cancer (BTC) is a highly aggressive malignancy with a poor prognosis; currently, limited biomarkers are available for early diagnosis and effective disease management. Therefore, it is essential to investigate reliable biomarkers for BTC patients. Peptidylarginine deimi...
Autores principales: | Lin, Hon-Yi, Yu, Chih-Chia, Chi, Chen-Lin, Wei, Chang-Kuo, Yin, Wen-Yao, Tseng, Chih-En, Li, Szu-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452823/ https://www.ncbi.nlm.nih.gov/pubmed/37627159 http://dx.doi.org/10.3390/cancers15164131 |
Ejemplares similares
-
Vimentin Is Involved in Peptidylarginine Deiminase 2-Induced Apoptosis of Activated Jurkat Cells
por: Hsu, Pei-Chen, et al.
Publicado: (2014) -
Features of the citrullinating peptidylarginine deiminase enzymes
por: Vossenaar, ER, et al.
Publicado: (2004) -
Expression of Peptidylarginine Deiminase Type 4 in Ovarian Tumors
por: Wang, Lin, et al.
Publicado: (2010) -
Functional Role of Dimerization of Human Peptidylarginine Deiminase 4 (PAD4)
por: Liu, Yi-Liang, et al.
Publicado: (2011) -
Putative Roles for Peptidylarginine Deiminases in COVID-19
por: Arisan, Elif Damla, et al.
Publicado: (2020)